Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Trump Dashboard

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Immunovant (IMVT)

NASDAQ:IMVT

US Market

IMVT

Immunovant

Analyst Forecasts

AI Stock Analysis

Technical Analysis

Historical Prices

News & Insights

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Advertisement

Immunovant (IMVT) Stock News & Sentiment

842 Followers

Immunovant’s IMVT-1402: A Promising Solution for Unmet Needs in Graves’ Disease

Ratings

Immunovant’s IMVT-1402: A Promising Solution for Unmet Needs in Graves’ Disease

30d ago

3 Best Stocks to Buy Now, 6/2/2025, According to Top Analysts

Market News

3 Best Stocks to Buy Now, 6/2/2025, According to Top Analysts

2M ago

Immunovant’s Promising Clinical Trials and Strategic Drug Focus Justify Buy Rating

Ratings

Immunovant’s Promising Clinical Trials and Strategic Drug Focus Justify Buy Rating

2M ago

Immunovant’s Promising Future: Buy Rating Backed by Strategic Advancements and Strong Cash Position

Ratings

Immunovant’s Promising Future: Buy Rating Backed by Strategic Advancements and Strong Cash Position

2M ago

Immunovant’s Strategic Developments and Financial Strength Justify Buy Rating

Ratings

Immunovant’s Strategic Developments and Financial Strength Justify Buy Rating

2M ago

Immunovant, Inc. Reports Strategic Progress and Financial Results

Company Announcements

Immunovant, Inc. Reports Strategic Progress and Financial Results

2M ago

IMVT Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Pre-Earnings

IMVT Earnings Report this Week: Is It a Buy, Ahead of Earnings?

2M ago

More IMVT News >

IMVT News on the Web

2025-07-25

Why Immunovant, Inc.’s (IMVT) Stock Is Down 7.48%

AAII

Neutral

2025-07-16

All You Need to Know About Immunovant (IMVT) Rating Upgrade to Buy

Zacks

Bullish

2025-07-16

Wall Street Analysts See a 137.68% Upside in Immunovant (IMVT): Can the Stock Really Move This High?

Zacks

Bullish

2025-07-02

Why Immunovant, Inc.’s (IMVT) Stock Is Up 5.57%

AAII

Neutral

2025-06-03

Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX), Dexcom (DXCM) and Immunovant (IMVT)

TipRanks News

Neutral

2025-06-02

Immunovant (IMVT) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

Bullish

2025-05-30

IMVT Q4 Loss Narrower Than Expected, Stock Up, Pipeline in Focus

Zacks

Neutral

2025-05-30

Jefferies Keeps Their Hold Rating on Immunovant (IMVT)

TipRanks News

Neutral

News Score - Last 7 Days

Neutral

IMVT

Sector Average

Media Buzz

This Week1 articles

Weekly Average1 articles

News Sentiment

This Week50%

Sector Average56%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IMVT’s Media Buzz Sentiment?

1 articles about IMVT were published this week. In an average week, 1 articles are published.

What is IMVT’s weekly average amount of articles?

In an average week, 1 articles about IMVT are published.

What is IMVT’s News Sentiment?

50% of articles about IMVT were positive this week, compared to its sector average of 56%.

Healthcare Stocks that are Trending in the News

WSTWest Pharmaceutical Services

NVSTEnvista Holdings

MTDMettler-Toledo

GMABGenmab

LHLabcorp Holdings

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing